首页>
外国专利>
Recombinant fusion protein produced by fusing Vibrio vulnificus flagellin and pathogenic antigens and the mucosal vaccine containing the same as an active ingredient
Recombinant fusion protein produced by fusing Vibrio vulnificus flagellin and pathogenic antigens and the mucosal vaccine containing the same as an active ingredient
PURPOSE: A recombinant fusion protein prepared by fusing antigen of pathogen with vaccine adjuvant and a vaccine for mucosal administration is provided to enhance PspA-specific antibody(IgG and IgA) generation. CONSTITUTION: A recombinant fusion protein is prepared by fusing protein antigen of pathogen with flagellin protein of Vibrio vulnificus. The flagellin is a FlaB of Vibrio vulnificus of sequence number 1. The antigen of pathogen is an alpha-helix domain and surface adhesion factor A(PsaA) of Streptococcus pneumoniae surface protein A(PsaA); subunit HA(hemagglutinin) and NA(neuraminidase) of influenza virus; or spike(S) protein of SARS virus. A vaccine for mucosal administration contains the recombinant fusion protein as an active ingredient.
展开▼